Sangon Biotech: difference between revisions
Diff·revision 4 → 5·11:40, 13 Dec 2024
Difference between revision 4 and revision 5 of Sangon Biotech. 3 lines changed; the page grew by 422 bytes.
| Revision 4 — 11:07, 11 Dec 2024 HarmReductionHen (talk) attribute range as a review estimate per talk 1,705 bytes ±0 | Revision 5 — 11:40, 13 Dec 2024 TallySheetTad (talk) rv promotional edit 2,127 bytes +422 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | == Corporate identity and history == | |
| + | 13 | Incorporated in 2004, the organisation has one of the longer histories among the entities covered here.{{r|registry}} Its catalogue is notably broader than the research-peptide sector norm, extending into general laboratory reagents, oligonucleotides and molecular-biology consumables, and its name appears in technical contexts unrelated to the research-compound trade.{{r|selfpub}} | |
| + | 14 | ||
| 12 | == References == | 15 | == References == |
| 13 | {{reflist}} | 16 | {{reflist}} |